1-8 of 8
G. Bociek, MD
Close
Sort by
Journal Articles

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Julie M. Vose, MD, John C. Chan, MD, Philip J. Bierman, MD, Alejandro Arevalo, MD, Fausto Loberiza, MD, Kai Fu, MD, Dennis Weisenburger, MD, Robert G. Bociek, MD, Martin Bast, BS, James O. Armitage, MD
Journal: Blood
Blood (2007) 110 (11): 3430.
https://doi.org/10.1182/blood.V110.11.3430.3430
Published: 2007
Journal Articles

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

James E. Talmadge, PhD, Ugur Coskun, PhD, Sarah Maas, MS, Orhan Turken, MD, Ziviko S. Pavletic, MD, Charles A. Kuszynski, PhD, Marcel Devetten, MD, Laura R. Schafer, MS, Lori Zobel, BS, Robert G. Bociek, MD
Journal: Blood
Blood (2007) 110 (11): 2994.
https://doi.org/10.1182/blood.V110.11.2994.2994
Published: 2007
Journal Articles

Mechanism of Alemtuzumab Depletion of T Cells in Stem Cell Products.

Dumrul Gulen, PhD, Robert G. Bociek, MD, Ugur Coskun, MD, Marcel P. Devetten, MD, James E. Talmadge, PhD
Journal: Blood
Blood (2006) 108 (11): 5176.
https://doi.org/10.1182/blood.V108.11.5176.5176
Published: 2006
Journal Articles

Differential T Cell Suppression by Two Different Pentostatin Conditioning Protocols for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Ugur Coskun, MD, Robert G. Bociek, MD, Zivko S. Pavletic, MD, Charlie Kuszynski, PhD, Marcel Devetten, MD, Laura Shafer, Lori Zobel, James E. Talmadge, PhD
Journal: Blood
Blood (2006) 108 (11): 5373.
https://doi.org/10.1182/blood.V108.11.5373.5373
Published: 2006
Journal Articles

Can Elimination of Total Body Irradiation (TBI) in Conditioning Regimens for Autologous Stem Cell Transplantation (SCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma Decrease the Risk of Secondary AML/MDS(sAML/MDS)? A Retrospective Case-Control Study at the University of Nebraska Medical Center.

Lori J. Maness, MD, F. R. Loberiza, MD, W. Sanger, PhD, M. P. DeVetten, MD, P. Bierman, MD, G. Bociek, MD, J. O. Armitage, MD, J. M. Vose, MD
Journal: Blood
Blood (2005) 106 (11): 682.
https://doi.org/10.1182/blood.V106.11.682.682
Published: 2005
Journal Articles

Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT).

Mary Lee H. Villanueva, MD, Fausto R. Loberiza, MD, MS, James O. Armitage, MD, Robert G. Bociek, MD, Apar Kishor Ganti, MD, James C. Lynch, PhD, Farhan Majeed, MD, Stefano R. Tarantolo, MD, Jo Torrey, RN, BSN, Julie M. Vose, MD, Philip J. Bierman, MD
Journal: Blood
Blood (2005) 106 (11): 1754.
https://doi.org/10.1182/blood.V106.11.1754.1754
Published: 2005
Journal Articles

Phase 2 Multicenter Trial of Gallium Nitrate in Patients with Advanced Non-Hodgkin’s Lymphoma (NHL).

Barbara Pro, MD, R. G. Bociek, MD, Christopher R. Chitambar, MD, Stephanie A. Gregory, MD, John P. Leonard, MD, Sandra Smith, Steven Novick, MD
Journal: Blood
Blood (2004) 104 (11): 2487.
https://doi.org/10.1182/blood.V104.11.2487.2487
Published: 2004
Journal Articles

Phase 3 Randomized Trial of Fludarabine/Cyclophosphamide Chemotherapy with or without Oblimersen Sodium (Bcl-2 Antisense; Genasense; G3139) for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).

Kanti R. Rai, MD, Joseph O. Moore, MD, Thomas E. Boyd, MD, Loree M. Larratt, MD, Anatoliy K. Golenkov, MD, Benjamin Koziner, MD, Asher Chanan-Khan, MD, R. G. Bociek, MD, Loretta M. Itri, MD
Journal: Blood
Blood (2004) 104 (11): 338.
https://doi.org/10.1182/blood.V104.11.338.338
Published: 2004